Cencora, Inc. (COR)
NYSE · Healthcare · Medical - Distribution
Profile
Cencora, Inc.
- Exchange
- NYSE
- Ticker
- COR
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Country
- US
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
Key facts
Cencora, Inc.: key facts
- Cencora, Inc. (NYSE: COR) is a Medical - Distribution company in the Healthcare sector.
- In fiscal 2025, Cencora, Inc. reported revenue of $321.3B and net income of $1.6B.
- Revenue grew 10.7% a year over the last 4 fiscal years.
- Free cash flow was positive in 5 of the last 5 fiscal years.
- Net income was positive in 5 of the last 5 fiscal years.
- Over the last twelve months, revenue was $332.8B and net income was $2.6B.
MonkScore
Cencora, Inc.'s MonkScore
MonkScore
MonkScore range: 70–80
as of October 2026
Sector rank: 190 of 628 in Healthcare
How this score is madeDisclaimer
Pillar ranges
- Growth90–100
- Profitability70–80
- Quality30–40
- Market Conviction50–60
- Safety20–30
The MonkScore runs from 0 to 100. Each range is one of ten 10-point groups, from 0–10 to 90–100.
Each pillar's range uses the same ten groups. The exact score and the pillar scores are in the MonkStreet app.
Fundamentals
Figures from the statements
Cencora, Inc.'s annual figures and the last twelve months, in USD. Last report: 30 June 2026.
| Figure | Last 12 months | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $332.8B | $321.3B | $294.0B | $262.2B | $238.6B | $214.0B |
| Gross profit | $12.3B | $10.1B | $8.7B | $7.8B | $7.6B | $6.3B |
| Operating income | $4.3B | $3.6B | $3.0B | $2.4B | $2.8B | $2.7B |
| Net income | $2.6B | $1.6B | $1.5B | $1.7B | $1.7B | $1.5B |
| Operating cash flow | $4.8B | $3.9B | $3.5B | $3.9B | $2.7B | $2.7B |
| Capital expenditure | -$760.8M | -$668.0M | -$487.2M | -$458.4M | -$496.3M | -$438.2M |
| Free cash flow | $4.1B | $3.2B | $3.0B | $3.5B | $2.2B | $2.2B |
| Total debt | $11.7B | $10.7B | $6.7B | $6.8B | $7.6B | $8.8B |
| Cash | $2.8B | $4.4B | $3.2B | $2.7B | $3.5B | $2.5B |
Revenue growth a year
- 1-year
- 9.3%
- 3-year
- 10.4%
- 4-year
- 10.7%
Compound growth between fiscal years.
Peers
Similar companies
- McKesson CorporationNYSE:MCKMonkScore range: 70–80
- Cardinal Health, Inc.NYSE:CAHMonkScore range: 70–80
- Henry Schein, Inc.NASDAQ:HSICMonkScore range: 60–70
- Akso Health GroupNASDAQ:AHGMonkScore range: 30–40
Score my top stocks · 14-day free trial · card required · not charged during the trial · cancel in one click
MonkStreet provides research, not investment advice.
Page built on 31 October 2026.